Oncology status update: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| Line 470: | Line 470: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anaplastic large cell lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 479: | Line 479: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Burkitt's lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 488: | Line 488: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Chronic lymphocytic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 497: | Line 497: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Chronic myelogenous leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 506: | Line 506: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Chronic neutrophilic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 515: | Line 515: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Diffuse large B cell lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 524: | Line 524: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Follicular lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 533: | Line 533: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hairy cell leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| Line 882: | Line 882: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hodgkin's lymphoma | ||
Hodgkin's lymphoma | |||
Leukemia (LP) | Leukemia (LP) | ||
Leukocytosis (SP) | Leukocytosis (SP) | ||
Revision as of 05:28, 3 July 2020
System leader: Farima Kahe, M.D.
List of Chapters Requiring Content
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | |||||||
In progress chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | |||||||
Completed chapters
| Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
|---|---|---|---|---|---|---|---|
| Oncology | Acute lymphoblastic leukemia | ||||||
| Acute myeloid leukemia | |||||||
| Acute promyelocytic leukemia | |||||||
| Adult T-cell leukemia | |||||||
| Anaplastic large cell lymphoma | |||||||
| Burkitt's lymphoma | |||||||
| Chronic lymphocytic leukemia | |||||||
| Chronic myelogenous leukemia | |||||||
| Chronic neutrophilic leukemia | |||||||
| Diffuse large B cell lymphoma | |||||||
| Follicular lymphoma | |||||||
| Hairy cell leukemia | |||||||
| Hodgkin's lymphoma
Leukemia (LP) Leukocytosis (SP) Hemophilia Lymphadenopathy Lymphangioma Lymphangiomyomatosis (SP) Lymphangiosarcoma (SP) Lymphoma (LP) Lymphomatoid granulomatosis Mast cell leukemia Mast cell tumor Multiple myeloma Myelodysplastic syndrome |